Colon and rectal cancer after renal transplantation

Expert Review of Anticancer Therapy

Volumn 8, Issue 8, 2008, Pages 1339-1346

  Kan, Manstein ^a   Gill, John S ^a   Wiseman, Sam M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Colon cancer; End stage renal disease; Rectal cancer; Renal transplantation

Indexed keywords

BEVACIZUMAB; CALCINEURIN INHIBITOR; CALCIUM CARBONATE; CYCLOOXYGENASE 2 INHIBITOR; FLUOROURACIL; IMMUNOSUPPRESSIVE AGENT; IRINOTECAN; OXALIPLATIN; RAPAMYCIN; STEROID;

ADJUVANT THERAPY; AVASCULAR NECROSIS; BARIUM ENEMA; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CARCINOGENESIS; CLINICAL TRIAL; COLON CANCER; COLONOSCOPY; COLORECTAL CANCER; DRUG INDUCED CANCER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIFE EXPECTANCY; RECTUM CANCER; RENAL REPLACEMENT THERAPY; REVIEW; CANADA; COLON TUMOR; FEMALE; INCIDENCE; MALE; PATHOLOGY; RECTUM TUMOR; RISK FACTOR; UNITED STATES;

CANADA; COLONIC NEOPLASMS; FEMALE; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; RECTAL NEOPLASMS; RISK FACTORS; UNITED STATES;

EID: 54549105243     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/14737140.8.8.1339     Document Type: Review

References (36)

1. Hawk ET, Umar A, Richmond E, Viner JL. Prevention and therapy of colorectal cancer. Med. Clin. North Am. 89(1), 85-110 (2005).
2. Lynch HT, De la Chapelle A. Hereditary colorectal cancer. N. Engl, J. Med. 348, 919-932 (2003).
3. Koushik A, Hunter DJ, Spiegelman D et al. Fruits, vegetables, and colon cancer risk in a pooled analysis of 14 cohort studies. J. Natl Cancer Inst. 99(19), 1471-1483 (2007).
4. Chan AT, Ogino S, Fuchs CS. Aspirin and the risk of colorectat cancer in relation to the expression of COX-2. N. Engl. Med. 356(21), 2131-2142 (2007).
5. Colangelo LA, Gapstur SM, Gann PH, Dyer AR. Cigarette smoking and colorectal carcinoma mortality in a cohort with long-term follow-up. Cancer 100(2), 223-224 (2004).
6. Chao A, Thun MJ, Jacobs EJ, Henley SJ, Rodriguez C, Calle EE. Cigarette smoking and colorectal cancer mortality in the cancer prevention study II. J. Natl Cancer Int. 92(23), 1888-1896 (2000).
7. Wu WK, Wong HE Luo, SW et al. 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone from cigarette smoke stimulates colon cancer growth via β-adrenoceptors. Cancer Res. 65(12), 5272 (2005).
8. Villeneuve PJ, Schaubel DE, Fenton SS et al. Cancer incidence among Canadian kidney transplant recipients. Am. J. Transplant. 7(4), 941-948 (2007).
9. Gutierrez-Dalmau A, Campistol JM. Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review. Drugs 67(8), 1167-1198 (2007).
10. Dantal J, Pohanka E. Malignancies in renal transplantation: an unmet medical need. Nephrol. Dial Transplant. 22(Suppl. 1), i4-i10 (2007).
11. Vajdic CM, McDonald SP, McCredie MR. Cancer incidence before and after kidney transplantation. JAMA 296(23), 2823-2831 (2006).
12. Buell JF, Papaconstantinou HT, Skalow B et al. De novo colorectal. cancer: five year survival is markedly lower in transplant recipients compared with the general population. Tansplant Proc. 37(2), 960-961 (2005).
13. Andrés A. Cancer incidence after immunosuppressive treatment following kidney transplantation. Crit. Rev. Oncol. Hematol. 56(1), 71-85 (2005).
14. Maisonneuve P, Agodoa. L, Gellert R. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 354(9173), 93-99 (1999).
15. Buccianti G, Maisonneuve P, Ravasi B et al. Cancer among patients on renal replacement therapy: a population-based survey in Lombardy, Italy. Int. J. Cancer 66(5), 591-593 (1996).
16. Vamvakas S, Baliner U, Heidland A Cancer in end-stage renal disease: potential factors involved. Am. J. Nephrol. 18(2), 89-95 (1998).
17. Lee S, Wasserberg N, Petrone P et al. The prevalence of colorectal neoplasia in patients with end-stage renal disease: a case-control study. Int. J. Colarecial Dis. 3(1), 47-51 (2008).
18. Stewart T, Henderson R, Grayson H, Opelz G. Reduced incidence of rectal cancer, compared to gastric and colonic cancer, in a population of 73,076 men and women chronically immunosuppressed. Clin. Cancer Res. 3(1), 51-55 (1997).
19. Webster AC, Craig JC, Simpson JM, Jones MP, Chapman JR. Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort of 15 183 recipients. Am. J. Tansplant. 7, 2140-2151 (2007).
20. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am. J. Transplant. 4(6), 905-913 (2004).
21. Saidi RF, Dudrick PS, Goldman MH. Colorectal cancer after renal transplantation. Tansplant Proc. 35(4), 1410-1420 (2003).
22. Johnson EE, Leverson GE, Pirsch JD, Heise CP. A 30-year analysis of colorectal adenocarcinoma in transplant recipients and proposal for altered screening. J. Gastrointest. Surg. 11(3), 272-279 (2007).
23. Wimmer CD, Rentsch M, Crispin A. Illner WD. The janus face of immunosuppression - de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich. Kidney Int. 71(12), 1271-1280 (2007).
24. Kehinde EO, Petermann A, Morgan JD. Triple therapy and incidence of de novo cancer in renal transplant recipients. Br. J. Surg. 81(7), 985-986 (1994).
25. Penn I. Tumors after renal and cardiac transplantation. Hematol. Oncol Clin. North Am. 7(2), 431-445 (1993).
26. Vilardell J, Oppenheimer F, Castelao AM et al. Cancer after transplantation in Catalonia. Transplant Proc. 24(1), 124 (1992).
27. Blohmé I, Brynger H. Malignant disease in renal transplant patients. Transplantation 39(1), 23-25 (1985).
28. Birkeland SA. Malignant tumors in renal transplant patients. The Scandia transplant material. Cancer 51(9), 1571-1575 (1983).
29. Grulich A, Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/ADIS compared with immunosuppressed transplant recipients: a meta analysis. Lancet 370, 59-67 (2007).
30. Ebisui C, Okazaki M, Kanai T et al. Clinicopathological study of colorectal cancers after renal transplantation. Tansplant Proc. 32(7), 1984-1985 (2000).
31. Wong G, Chapman JR, Craig JC. Cancer screening in renal transplant recipients: what is the evidence? Clin. J. Am. Soc. Nephrol. 3(Suppl. 2) s87-s100 (2008).
32. Kasiske BL, Cangro CB, Hariharan S et al. The evaluation of renal transplantation candidates: clinical practice guidelines. Am. J. Transplant. 1 (Suppl. 2), 3-95 (2001).
33. Parikshak M, Pawlak SE, Eggenberger JC. The role of endoscopic colon surveillance in the transplant population. Dis. Colon Rectum. 45(12), 1655-1660 (2002).
34. Papaconstantinou HT, Sklow B, Hanaway MJ et al. Characteristics and survival patterns of solid organ transplant patients developing de now colon and rectal cancer. Dis. Colon Rectum. 47(11), 1898-1903 (2004).
35. Wong G, Howard K, Craig, J, Chapman J. Cost-effectiveness of colorectal cancer screening in renal transplant recipients. Transplantation 85(4), 532-541 (2008).
36. Ajithkumax TV, Parkinson CA, Butler A, Hatcher HM. Management of solid urnouts in organ-transplant recipients. Lancet Oncol. 8(10), 921-932 (2007).